KTOV Kitov Pharma Ltd.

1.01
+0.01  (+1%)
Previous Close 1
Open 0.98
Price To Book 1.87
Market Cap 19632213
Shares 19,437,835
Volume 116,176
Short Ratio
Av. Daily Volume 881,768

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approval announced May 31, 2018.
KIT-302
Osteoarthritis and Hypertension
Phase 1/2 trial to be initiated 2H 2019.
NT-219
Squamous cell carcinoma of the head & neck (SCCHN)

Latest News

  1. Kitov Receives Notice of Allowance for Additional U.S. Patent Covering its Commercial Product Consensi™
  2. Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference
  3. Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack
  4. Kitov Announces Key Milestone in FameWave Acquisition
  5. FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo®)
  6. Potential Milestones Coming for Kitov Pharma and Product Commercialization Plans
  7. These Four Healthcare Stocks Could Test March Highs
  8. Kitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology Company
  9. Kitov Pharma Reports Year End 2018 Financial Results and Provides Business Update
  10. A Biotech Play You Can't Afford To Miss
  11. Kitov Closes $6 Million Registered Direct Offering
  12. Small Caps Soaring Off of Bottoms
  13. Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY
  14. Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings
  15. Kitov Announces Pricing of $6 Million Registered Direct Offering
  16. 4 Healthcare Stocks Seeing Gains On Wednesday (1/16/19)
  17. Kitov Pharmaceuticals News: KTOV Stock Up on Anti-Cancer Drug Findings
  18. New Data on Kitov’s NT219 Demonstrates its Unique Mechanism of Action and Anti-Cancer Effect
  19. 4 Healthcare Stocks Making Moves On Monday (1/7/19)
  20. 4 Healthcare Stocks Gaining Speed on Thursday (1/3/19)